Aimed Bio Inc.

Public

Aimed Bio Inc. is now publicly traded

The data on this page reflects Aimed Bio Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Private Equity

Jun 2, 2025

Total Funding Raised

$66.45M

Company Overview

Aimed Bio Inc. is a biotechnology company that develops antibody-based therapeutics, including antibody-drug conjugates (ADCs), for refractory brain diseases and cancer.

AI Layer

Non-AI

Keywords

antibody-drug conjugatesADCsoncology drug discoverypatient-derived cell modelsPDC modelsdrug licensingtarget discoveryclinical-stage biotechprecision oncologymulti-omics platformpatient-derived xenograft modelsPDX modelssolid tumor therapeuticsbiopharma partnershipsantibody therapeuticsbiomarker discoverymilestone-based licensing

Aimed Bio Inc. Comparables

Compare Aimed Bio Inc. with similar companies based on industry and business-model similarity.

Aimed Bio Inc. comparables — related companies by embedding similarity
Company	Similarity	Market Cap
GeneQuantum Healthcare	86%
Duality Biotherapeutics Inc	85%
MediLink Therapeutics	84%

View all Comparables

Aimed Bio Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Private Equity	Jun 2, 2025
Series B	Jul 31, 2024
Strategic	Sep 13, 2023

View all Funding Rounds

Aimed Bio Inc. Investors

Notable investors and investment history

Aimed Bio Inc. investors
Investor	Rounds
InterVest	Series B, Private Equity
Samsung Life Public Welfare Foundation	Private Equity
DS Asset Management	Series B, Private Equity
Mirae Asset Securities	Private Equity
Mint Venture Partners	Series B

View all Investors

Aimed Bio Inc. Filings

Explore SEC and related filing metadata, where available.

Aimed Bio Inc. filings preview — column headings only; records require access
Type	Date	Amount Offered	Amount Sold	Filing	Pages	Download

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Firmographic Details

Headquarters—

Employee Range14

Year Founded2018

Last FundingJun 2, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?